Throat Cancer
10
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (10)
DESTINY-PANTUMOUR04
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
Somesthesia in Cancer Patients: Variability and Influence on Eating Experience
Quest to Analyze One Thousand Humans Meditating
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Fecal Screening Assay for Taiwanese Population